Abstract
The objective of the study was to identify predictive biomarkers and generate the model to predict placental lesions in women with varicose veins. We collected serial serum specimens from 128 women with varicose veins between 22 and 24 weeks’ gestation. The investigation includes ultrasound findings, blood analysis of endothelin-1, vascular endothelial growth factor (VEGF), CRP, coagulation factors as well as BMI. We used machine learning algorithm and multivariable logistic regression with Lasso method to predict placental lesions among the pregnant patients with varicose veins.A total of 47 (36.7 %) women with varicose veins subsequently developed placental insufficiency. Mean serum VEGF were higher in women who developed placental insufficiency – 29 (27–31) pg/ml, as compared with women without varicose disease – 24 (22–25) pg/ml, p < 0.001. The performance of the model trained with all the most valuable tests (VEGF, endothelin, CRP, D-dimers, fibrinogen, CEAP class) is admissible (AUC 0.94; CI 0.842–0.956; p < 0.001).We identified novel combination of clinical and laboratory predictive markers that provide pathophysiological insights and could help future improvements of diagnosis and treatment of placental lesions in women with varicose veins.
Highlights
The objective of the study was to identify predictive biomarkers and generate the model to predict placental lesions in women with varicose veins
Mean serum vascular endothelial growth factor (VEGF) were higher in women who developed placental insufficiency – 29 (27–31) pg/ml, as compared with women without varicose disease – 24 (22–25) pg/ml, p < 0.001
We identified novel combination of clinical and laboratory predictive markers that provide pathophysiological insights and could help future improvements of diagnosis and treatment of placental lesions in women with varicose veins
Summary
Что угроза преждевременных родов при беременности на фоне варикозного расширения вен нижних конечностей встречалась в 2,2 раза чаще, чем у женщин без варикозного расширения вен нижних конечностей Статистически значимых различий по преэклампсии нами не выявлено: χ2 составил 0,02 ( р = 0,877), однако следует отметить, что указанное осложнение гестации встречалось у каждой 5-й беременной основной (20,3 %) и контрольной (19,3 %) групп. Учитывая роль дисбаланса между веществами с вазодилатирующими и сосудосуживающими свойствами в возникновении системных нарушений микроциркуляции при беременности [19, 20], нами проведен сравнительный анализ концентрации фактора роста эндотелия сосудов и вазоконстрикторного фактора – эндотелина у беременных женщин исследуемых групп Сравнительный анализ маркеров эндотелиальной дисфункции у беременных женщин исследуемых групп, Ме (LQ – UQ)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the National Academy of Sciences of Belarus, Medical series
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
